– Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector – – Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO Capabilities to Establish an Integrated Solution from Discovery through CGMP Manufacturing –...
DURHAM, North Carolina(GLOBE NEWSWIRE)—Bioventus Inc. (“Bioventus” or the “Company”) today announced the pricing of its initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $13.00 per share. The Company’s Class A common...
WATERTOWN, Massachusetts (GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced that the first...
New York, NY –– EW Healthcare Partners (“EW”), a private equity firm dedicated to making growth equity investments in rapidly growing healthcare companies, announced the closing of EW Healthcare Partners Acquisition Fund (“EW-AF” or the “Fund”). The Fund was formed as...
BOSTON, Massachusetts—PRNewswire—Haemonetics Corporation (NYSE: HAE) (“Haemonetics”), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive...
Robert S. White Joins Board of Directors SANTA CLARA, California (GLOBE NEWSWIRE)—Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the completion of a $45 million equity financing round. The equity round included new investor EW...
Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management. EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and Former Medtronic Chairman and CEO William Hawkins to Join MiMedx Board of Directors...
Providing large scale manufacturing capacity for AZD1222 Keele, UK, 16 June 2020: Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, today announced it has signed a supply agreement with...
San Antonio – April 30, 2020 — SARS-CoV-2 is a global threat for which the world was unprepared. Xenex Disinfection Services announced today that its LightStrike™ pulsed xenon disinfection robot is the first and only ultraviolet (UV) disinfection technology proven to...
